Cover Image
Market Research Report

Chinese Orthopedic Biomaterials Market

Published by iData Research Inc. Product code 274587
Published Content info 110 Pages
Delivery time: 1-2 business days
Price
Back to Top
Chinese Orthopedic Biomaterials Market
Published: June 26, 2013 Content info: 110 Pages
Description

The Chinese orthopedic biomaterials market is expected to approach $522.3 million by 2019. The bone graft substitute segment is expected to constitute the majority of the Chinese orthopedic biomaterials market.

The Chinese orthopedic biomaterials market comprises bone graft substitutes which is segmented into allografts, demineralized bone matrices (DBM) and synthetics, and hyaluronic acid (HA) viscosupplementation. The market has seen increased interest in domestic competitors and some domestic competitors are in the process of clinical trials for synthetic, DBM, and bone morphogenetic protein (BMP) products. Further growth in the overall market will be fuelled by the Chinese government improving healthcare coverage across the country, leading to an increase in the number of Chinese people with more disposable income. The previous drivers are magnified by the increasing population of elderly, and the increased acceptance of surgery as a solution.

Scope:

This report pertains to a forecast period of 10 years (2009 - 2019) for China.

Report Contents:

  • Competitor Analysis
  • Identified Strategic Opportunities
  • Market Overview by Segment & Country
  • Trend Analysis by Segment & Country
  • Market Drivers & Limiters
  • Mergers & Acquisitions
  • Customer Feedback and Market Monitoring

Main Markets Included:

  • Bone Graft Substitute
  • Hyaluronic Acid Viscosupplementation

Sub-Segments Included:

  • Synthetic Allograft
  • Demineralized Bone Matrix
  • Cervical Spine
  • Thoracolumbar Spine
  • Trauma & Reconstruction
  • Craniomaxillofacial
  • Single-injection products
  • Three-injection cycle products
  • Five-injection cycle products

Companies Included:

  • Wright Medical
  • Bloomage Freda Biopharm
  • Shanghai Haohai Biological
  • Kunming Baker Norton
  • Shanghai Baijiayi
  • Xin Kang Cheng
  • Shanxi Aurui
  • Biolu
  • Hubei Lianjie
  • Shanghai Anjiu
  • Biocomposites
  • DePuy Synthes NovaBone
  • Rebone

Others Include:

Award Trade Corporation (Kunming), Beijing Fito Medical, Beijing St. Jane Medical, Liweize Medical Devices, Shanghai Medcare, Shenzhen SMARL, and various domestic companies

Reasons To Buy:

This report analyzes and evaluates the current state of the market including existing and potential markets, product average selling prices, and unit volumes. The report also highlights the opportunities and potential hazards involved, and presents strategies for successfully navigating the market landscape. Furthermore, it seeks to identify the trends and technologies that will affect the future of each market segment and prepares an unbiased critical assessment of such market drivers and limiters based on our “ground up” approach, which includes primary and secondary research methods.

Table of Contents
Product Code: iDATA_CHOB13_RPT

Table of Contents

TABLE OF CONTENTS

LIST OF FIGURES

LIST OF CHARTS

EXECUTIVE SUMMARY

  • 1.1. CHINESE MARKET FOR ORTHOPEDIC BIOMATERIALS
  • 1.2. GROWTH TRENDS BY SEGMENT
  • 1.3. PROCEDURES
  • 1.4. BONE GRAFT SUBSTITUTE MARKET
  • 1.5. HYALURONIC ACID VISCOSUPPLEMENTATION MARKET
  • 1.6. COMPETITIVE ANALYSIS

RESEARCH METHODOLOGY

  • 2.1. RESEARCH SCOPE
  • 2.2. IDATA'S 9-STEP METHODOLOGY
    • Step 1: Project Initiation & Team Selection
    • Step 2: Prepare Data Systems and Perform Secondary Research
    • Step 3: Preparation for Interviews & Questionnaire Design
    • Step 4: Performing Primary Research
    • Step 5: Research Analysis: Establishing Baseline Estimates
    • Step 6: Market Forecast and Analysis
    • Step 7: Identify Strategic Opportunities
    • Step 8: Final Review and Market Release
    • Step 9: Customer Feedback and Market Monitoring

CHINESE ORTHOPEDIC BIOMATERIALS MARKET

  • 3.1. INTRODUCTION
    • 3.1.1. Growth Factors
    • 3.1.2. Bone Graft Substitutes
    • 3.1.3. Hyaluronic Acid Viscosupplementation
  • 3.2. CURRENCY EXCHANGE RATE
  • 3.3. PROCEDURES
    • 3.3.1. Total Orthopedic Bone Graft Substitute Procedures by Indication
    • 3.3.2. Total Orthopedic Bone Graft Substitute Procedures by Segment
    • 3.3.3. Bone Graft Substitute Procedures
    • 3.3.4. Hyaluronic Acid Viscosupplementation Procedures
  • 3.4. MARKET OVERVIEW
  • 3.5. TREND ANALYSIS
  • 3.6. MARKET DRIVERS AND LIMITERS
    • 3.6.1. Market Drivers
    • 3.6.2. Market Limiters
  • 3.7. COMPETITIVE ANALYSIS
    • 3.7.1. Leading Competitors
    • 3.7.2. Market Concentration
  • 3.8. MERGERS AND ACQUISITIONS

BONE GRAFT SUBSTITUTE MARKET

  • 4.1. INTRODUCTION
    • 4.1.1.1. Autograft
    • 4.1.1.2. Non-Proprietary Allograft
    • 4.1.1.3. Demineralized Bone Matrix
    • 4.1.1.4. Synthetic
    • 4.1.2. Volumes Represented per Procedure
  • 4.2. MARKET OVERVIEW
  • 4.3. MARKET ANALYSIS & FORECAST
    • 4.3.1. Allograft Market
      • 4.3.1.1. Total Allograft Market
    • 4.3.2. Synthetic Market
      • 4.3.2.1. Total Synthetic Market
    • 4.3.3. Demineralized Bone Matrix Market
      • 4.3.3.1. Total DBM Market
    • 4.3.4. Market by Indication
    • 4.3.5. Cervical Market
    • 4.3.6. Thoracolumbar Market
    • 4.3.7. Trauma & Reconstruction Market
    • 4.3.8. Craniomaxillofacial Market
      • 4.3.8.1. Craniomaxillofacial Market
  • 4.4. DRIVERS AND LIMITERS
    • 4.4.1. Market Drivers
    • 4.4.2. Market Limiters
  • 4.5. COMPETITIVE ANALYSIS

HYALURONIC ACID VISCOSUPPLEMENTATION MARKET

  • 5.1. INTRODUCTION
    • 5.1.1.1. Single-Injection Products
    • 5.1.1.2. Three-Injection Cycle Products
    • 5.1.1.3. Five-Injection Cycle Products
  • 5.2. MARKET OVERVIEW
  • 5.3. MARKET ANALYSIS & FORECAST
    • 5.3.1. Single Injection Market
    • 5.3.2. Three Injection Cycle Market
    • 5.3.3. Five Injection Cycle Market
  • 5.4. DRIVERS AND LIMITERS
    • 5.4.1. Market Drivers
    • 5.4.2. Market Limiters
  • 5.5. COMPETITIVE ANALYSIS

APPENDIX: (OPTIONAL)

ABBREVIATIONS

Back to Top